Recall Register

Drug recall: Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c).…

Class II FDA enforcement event 84657. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

CGMP Deviations: Presence of NDMA impurity detected in product.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Denton Pharma, Inc. started this drug recall on 20 Dec 2019. The firm address in the FDA record is in North Blenheim, NY. FDA put the recall in Class II. FDA event 84657 has 2 product records. The first FDA enforcement report date is 29 Jan 2020. The record gives the status Terminated, with the termination date 5 Oct 2023. 89 of the 362 drug events that started in 2019 have more product records. The median drug event of 2019 has 1 product record. The openFDA file has 362 drug events that started in 2019 and 367 that started in 2018.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

Denton Pharma, Inc., North Blenheim, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 84657: product records
Recall numberProductQuantityClassStatusReport date
D-0794-2020Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-count bottle (NDC 70934-017-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131.1,341 bottlesClass IITerminated29 Jan 2020
D-0795-2020Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131467 bottlesClass IITerminated29 Jan 2020

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2019
362
Share of these events in Class II
68%
Product records in this event
2Median of the firm: 2
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of Denton Pharma, Inc.
InitiatedProduct (first record)TypeClassRecords
8 Oct 2020Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., RepackagedDrugClass II2

Official channels

Cite this page

Recall Register. FDA enforcement event 84657. https://recallregister.com/fda/ii/84657/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 84657?
The event has 2 product records. The first record gives this quantity: 1,341 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2019 have the same class?
68% of the 362 drug events that started in 2019 are in Class II.